FactMR has released its latest report on the Vascular Closure Devices Market, offering in-depth insights into the global market’s robust growth driven by the rising prevalence of cardiovascular diseases, advancements in minimally invasive technologies, and increasing demand for rapid hemostasis solutions. Valued at USD 954.6 million in 2024, the market is projected to grow at a compound annual growth rate (CAGR) of 7.3%, reaching USD 2,065 million by 2035. This expansion underscores the critical role of vascular closure devices (VCDs) in improving patient outcomes and streamlining post-procedure recovery.
Market Outlook and Growth Projections
The vascular closure devices market is set for significant growth from 2025 to 2035, fueled by the increasing adoption of minimally invasive procedures such as angiography, angioplasty, and stent placement. VCDs are essential for achieving hemostasis at vascular access sites, reducing complications, and enabling faster patient recovery compared to traditional manual compression. The report projects the market to grow from USD 954.6 million in 2024 to USD 2,065 million by 2035, with a CAGR of 7.3%. This growth is driven by rising cardiovascular disease rates, technological innovations in device design, and the global shift toward same-day discharge protocols in healthcare settings.
For more information, visit https://www.factmr.com/report/vascular-closure-devices-market
Comments
0 comment